Verve’s shares jump by more than 26% on Lilly-partnered gene therapy data
Verve Therapeutics saw its stock surge by more than 26% when markets opened today (14 April) after the company announced…
All articles by Jenna Philpott
Jenna Philpott
Jenna Philpott is a news and features reporter for Pharmaceutical Technology. Jenna holds a BSc in Biochemistry and has interests in rare diseases, gene therapies, and oncology. Contact Jenna
-
-
Sandoz challenges Amgen’s Enbrel patents in US antitrust lawsuit
Sandoz has filed an antitrust lawsuit in the US against Amgen, challenging alleged anti-competitive practices surrounding the biologic blockbuster Enbrel…
-
Novartis commits $23bn to US manufacturing amid tariff threats
Novartis will invest $23bn in US-based manufacturing and research and development (R&D) over the next five years, becoming the latest…
-
FDA to phase out animal testing with AI and lab-based models
The US Food and Drug Administration (FDA) has announced plans to begin replacing animal testing in drug development with “more…
-
Keros Therapeutics considers sale amid investor pressure
Keros Therapeutics’ board of directors has authorised a ‘poison pill defence’— in response to increasing investor interest in “influencing the…
-
MHRA reconfirmed as WHO biologics partner amid US withdrawal
The World Health Organization (WHO) has confirmed the redesignation of the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) as…
-
Merida launches with $121m to target autoimmune antibodies
US biotech Merida Biosciences has launched with $121m in Series A financing to develop therapeutics targeting disease-causing antibodies in autoimmune…
-
Pharma CEOs warn EC President of “risk of exodus” to US
As trade tensions escalate and new potential US tariffs loom over the pharma sector, Europe’s largest drugmakers are warning that…
-
Epsilogen acquires TigaTx to expand pan-isotope cancer antibody pipeline
UK biotech Epsilogen has acquired US-based antibody developer TigaTx in a deal that collates work from the two companies’ alternative…
-
EU president to meet pharma leaders as tariff threat looms
European Commission (EC) President Ursula von der Leyen is set to hold talks with senior pharmaceutical executives today (8 April),…